Chronic inhalation bioassays in rodents are used to assess pulmonary carcinogenicity for purposes of hazard identification and potentially for risk characterization. The influence of high experimental doses on tumor development has been recognized for some time and has led to the concept of maximum tolerated dose (MTD) for dose selection, with the highest dose being at the MTD. Exposure mind. This is due to several problems associated with determining an appropriate MTD for particle inhalation studies. One requirement for the MTD is that some toxicity should be observed. However, it is difficult to define what degree of toxic response is indicative of the MTD. For particle inhalation studies, various noncancer end points in addition to mortality and body weight gain have been considered as indicators of the MTD, i.e., pulmonary inflammation, increased epithelial cell proliferation, increased lung weight, impairment of particle clearance function, and significant histopathological findings at the end of a subchronic study. However, there is no general agreement about quantification of these end points to define the MTD. To determine whether pulmonary responses are indicative of the MTD, we suggest defining an MTD based on results of a multidose subchronic and chronic inhalation study with a known human particulate carcinogen, e.g., asbestos or crystalline silica. Quantification of effects in such a study using the noncancer end points listed above would identify a dose level without significant signs of toxicity at the end of the subchronic study. If this dose level still results in significant lung tumor incidence at the end of the chronic study. We will have a sound basis for characterizing the MTD and justifying its use in future particle inhalation studies. Also, a better understanding of cellular and molecular mechanisms of particle-induced lung tumors is needed to support the MTD concept. Environ Health Perspect 105(Suppl 5): 1347-1356 (1997) 
Introduction
The rodent carcinogenicity assays generally toxicity or even mortality from causes other involve dosing animals over a 2-year period. than cancer. This problem has been recogHistorically, high dose levels have often nized for some time, and guidelines were been selected which could induce significant proposed to limit the highest dose in such This paper is based on a presentation at The Sixth International Meeting on the Toxicology of Natural and ManMade Fibrous and Non-Fibrous Particles held 15-18 September 1996 in Lake Placid, New York. Manuscript received at EHP27 March 1997; accepted 3 July 1997. assays to the maximum tolerated dose (MTD) (1) . These guidelines were based mainly on results from the oral exposure route, and although the same principles apply to other routes of animal dosing, there are specific differences that must be considered when applying the concept of the MTD to chronic particle inhalation studies. In this brief review of the pulmonary carcinogenicity observed in particle inhalation studies with rodents and the underlying potential mechanistic events, we identify respective problems with the current MTD definition. We conclude with a suggestion for defining the MTD for particle inhalation studies.
Particle Inhalation Studies and High-dose Effects Table 1 lists several nonfibrous and fibrous particles which were used in chronic inhalation studies in rats and which induced lung tumors in this species. This list includes particles of low cytotoxicity such as carbon black, talc, and TiO2, as well as cytotoxic particles such as quartz and various types of asbestos. All of these particles are poorly or only moderately soluble in the lung. Although it is conceivable that mechanisms of lung tumor induction in rats differ between fibrous and nonfibrous particles, the studies with particles listed in Table 1 were performed with inhaled concentrations (up to 250 mg/m3) much higher than those to which humans are exposed. One reason for using high exposures in these studies is to assure that the animals are adequately dosed so that during the short lifespan of a rat-compared to humans-the detection of potential carcinogenic effects is maximized. In the case of TiO2, a difference between ultrafine TiO2 particles (particle diameter -20 nm) and pigment grade TiO2 (particle diameter 200-300 nm) should be noted: An inhaled mass concentration more than an order of magnitude lower and respectively lower gravimetric lung burdens of the ultrafine particles compared to the larger sized TiO2 resulted in similar lung tumor incidence (2, 3) . This result is of interest, as it suggests that the term dose should not be used narrowly as a gravimetric lung burden only, and that other particle parameters can be more appropriate dosemetrics as discussed below.
Based on the available data, our current knowledge of particle-induced lung tumors in rats can be summarized by stating that all inhaled particles-fibrous and nonfibrous-are likely to induce lung tumors in rats provided the particles are a) inhaled chronically at high concentrations, b) rat respirable, and c) of low in vivo solubility. The retained lung burden leading to induction of lung tumors can differ, depending on particle cytotoxicity, particle size, and particle shape, but is greater than 1 mg/g of lung for low toxicity particles. Although some of the particles listed in (6) . Chronic alveolar inflammation occurred as well. The presence of impaired AM-mediated particle clearance and chronic inflammation did not always result in a tumorigenic response in the rat studies, i.e., if these effects were only moderate. However, lung tumors were never found in rats when particle overload induced impaired clearance, and pulmonary inflammation were absent during chronic inhalation of particles (7).
Respective dose-response relationships are consistent with a threshold dose above which lung tumors could be induced by a mechanism that may not be operative at lower doses. Figure 1 depicts the result of the 2-year inhalation study in rats with pigment grade TiO2 (particle size 200-300 nm) at exposure concentrations of 10, 50, and 250 mg/m3 (2) . For purposes of comparison with ultrafine TiO2 (particle size -20 nm) reported in another study (3) , the exposure term in Figure 1 is expressed as exposure concentration x duration (g/m3 x hr). For pigment grade TiO2, lung tumor incidence was increased only at the highest concentration, with a lung burden of 665 mg per rat lung. The realization that this result in the rat is secondary to toxicity based on lung particle overload led the U.S. Environmental Protection Agency (U.S. EPA) to remove TiO2 from its toxic release inventory (8) . Since other rodent species do not show this response, the appropriateness of using the rat model in a cancer bioassay with inhaled particles was questioned. Doubts about human extrapolation from rat studies were reinforced by findings of high particulate lung burdens in coal miners [up to 40 mg/g lung (9)] that did not lead to an increased risk of lung cancer in this group of heavily exposed humans. (5) . However, rats exposed to 200 mg/m3 coal dust (Table 1) developed lung tumors, although the number of animals in the study was low (10) .
Thus, it seems to be firmly established that rats respond with lung tumor induction at chronic high exposures to poorly soluble particles of low toxicity, which results in the retention of high lung doses. However, even low exposure concentrations to such particles can induce lung tumors in rats. As mentioned before and shown in Figure 1 , a 2-year inhalation study by Heinrich et al. (3) showed that ultrafine TiO2 can increase lung tumor incidence in rats at much lower exposures and respective lower gravimetric lung burdens than were observed with larger sized pigment grade TiO2 in the study by Lee et al. (2) . TiO2 lung burdens were 665 mg (pigment grade TiO2) and 39 mg (ultrafine TiO2). Exposure, g/m3xhr Figure 1 . Exposure-response relationship of lung tumor incidence in rats after 2-year exposure to pigment grade TiO2 particles (2), demonstrating a nonlinear response. Also shown is the result of a 2-year exposure to ultrafine TiO2 particles (3) .
two studies can explain their differing biological activities, as demonstrated in a subchronic inhalation study in rats comparing pulmonary effects of pigment grade TiO2 and ultrafine TiO2 (11, 12) . In this study, pulmonary inflammatory response and impairment of AM-mediated dearance correlated best with the surface area rather than the mass of the retained particles. Further, a dosimetric evaluation of particle-induced carcinogenic responses in the rat revealed that particle surface area rather than mass, volume, or number of the retained particles correlated best with lung tumor incidence (13) . To use the appropriate dose parameter is therefore crucial, and particle surface area appears to be the best descriptor. The concept that the surface area is a more relevant dose parameter than the mass of poorly soluble particles is very plausible as it is the surface of an insoluble particle which interacts with cellular and subcellular structures to elicit biological responses.
Most recently, Driscoll (14) reinforced the surface area concept when he compared the rat lung tumor response in a number of particle inhalation studies with the mass or surface area of the retained particles. Only the surface area showed a highly significant correlation, as demonstrated in Figure 2 . The ultrafine TiO2 dose retained in rat lungs in the study by Heinrich et al. (3), expressed as particle surface area, is in the range of the high dose of pigment grade TiO2 in the study by Lee et al. (2) . Figure 2 demonstrates again that particle-induced lung tumors in rats are a phenomenon of high doses (dose expressed as particle surface area) and that a threshold may exist below which the retained dose of particle surface area is too low to induce tumors. Because the ratio of particle surface area to particle mass can differ greatly among In contrast to the rat, lung tumors have not been observed in mice and hamsters after chronic high-level exposures to nonfibrous particles of low solubility. Resistance to lung tumor induction in these two rodent species was evident in lung burdens of particles (i.e., talc, carbon black, diesel soot) that were as high as those in the rat studies, which resulted also in impaired clearance function of AM in mice and hamsters [reviewed by lung tumor Oberd6rster (7)]. However, the pulmonary various par-inflammatory response elicited by particles face area of was less pronounced in mice and hamsters, urve is con-suggesting significant species differences in this response. With respect to inhaled fibrous particles, the hamster appears to be articles of more likely to respond with mesothelioma burden in than the rat but does not respond with is particle lung tumors (17); the only chronic inhalaated with tion study in mice with fibers [chrysotile s. This is (18) ] found that both lung tumors and D2 in the mesotheliomas were induced.
d particle
In conclusion, lung tumor induction igh mass by inhalation of poorly soluble particles of low cytotoxicity (which showed negative guments results in genotoxicity assays) is highly lose para-species specific and only occurs at high erse pul-dose levels. This may imply that a secence, the ondary mechanism of genotoxicity plays a is in coal role and that consequently certain defense i a differ-mechanisms are better developed in one f particle species compared to others and provide r species, protection. Because the rat appears to be ied mass most sensitive with respect to lung tumor lung ( Mechanism of Partide-induced Lung Tumors in Rats Our present understanding of the cascade of events occurring in the rat lung during particle exposure is summarized in Figure 3 . During chronic exposure to high concentrations of inhaled particles, phagocytosis by AM of particles deposited in the alveolar region results in AM activation, with release of a number of mediators including cytokines and chemokines. These mediators effect the recruitment of additional inflammatory cells, neutrophils (PMN), and macrophages, whose activation amplifies the existing inflammatory process through the release of additional inflammatory cytokines, growth factors, and reactive 02-and Nspecies (19, 20) . The mitogenic activity of growth factors on epithelial target cells (e.g., type II cells) leads to an increase in their proliferation rate. In addition, an increase in target cell mutation rates via the action of reactive species (02-derived, N-derived, lipid peroxidation products) may occur, representing a secondary mechanism of particleinduced genotoxicity, with chronic alveolar inflammation playing a central role.
The inflammatory mechanism of particle-induced genotoxicity leading to lung tumors in rats is supported by a number of observations from both in vitro and in vivo studies. The knowledge that activated inflammatory cells can mediate a mutagenic response via released oxidants dates back to in vitro studies with human leukocytes and monocytes inducing bacterial mutations and modifications of DNA bases [reviewed by Weitzman and Gordon (21) ]. First evidence supporting the inflammatory mechanism of particle-induced genotoxicity was provided by Driscoll (14) in ex vivo studies that showed that inflammatory cells obtained from the lungs of a-quartz-exposed rats are mutagenic to rat alveolar epithelial cells and that the mutagenic effect could be attenuated by the addition of antioxidants. PMN appeared to be the most mutagenic inflammatory cells. Furthermore, a 3-month inhalation exposure of rats to carbon black particles confirmed that significantly increased in vivo mutation rates of alveolar epithelial cells occurred only in those groups that also showed a significant neutrophiic inflammation (22) . Figure 4 shows similar results after intratracheal administration of high doses of different particle types to rats (23 (24) (25) (26) , or in the case of extracellular SOD, a tetrameric form in mice and humans compared to a dimeric form in rats that leaves the rat pulmonary interstitium poorly protected enzymatically against superoxide radicals (27) . Other potential mechanisms for the greater resistance of mice to particle-induced lung tumors may be related to differences in DNA repair mechanisms, apoptosis of transformed cells, or expression of antiinflammatory cytokines. With respect to the latter, IL-10 expression was reported to be significantly increased in lung lavage cells of mice after exposure to quartz (28), whereas IL-10 was not detectable after quartz treatment in rats (29) . This suggests that the generally lower pulmonary inflammatory response in mice after partide exposure (30-33) may be due in part to greater expression of antiinflammatory cytokines. Thus, the greater carcinogenic response to particles in rats compared with that of other rodent species may not be due to the inflammatory mechanism operating only in rats at high doses but may be due to differences in the level of the combined antioxidant and antiinflammatory defenses. At low particle doses in the lung, mechanisms of toxicity are well balanced by mechanisms of defense, but at high particle doses this balance becomes tilted toward toxic mechanisms, which in the rat eventually leads to tumor induction via oxidant-induced genotoxicity. The result is an apparent dose dependency of cellular mechanisms of toxicity and carcinogenicity. Principally, these toxic mechanisms could also operate in other species yet do not surface because of better developed defenses.
Molecular mechanisms of carcinogenicity have also been found to be dose dependent. Maronpot et al. (34) reviewed data showing that k-ras mutations in nitrosamineinduced lung and liver tumors occur at low but not at high doses. The apparent dose dependency of cellular and molecular mechanisms of carcinogenicity through the impact of toxicity challenges the basic assumption for carcinogenic risk assessment that turmors are induced by the same mechanism at low and high doses. The shape of the dose-response curve will be very flat in the low-dose region if mechanisms differ from low to high dose as discussed above. It is not known presently whether the suggested inflammatory mechanisms of secondary genotoxicity in particle-induced carcinogenesis described in Figure 3 Several difficulties arise when applying these recommendations for conducting a study. One problem is that the MTD to be used in the 2-year chronic study is determined from a 3-month subchronic study. Minimal changes in toxicity occurring at the 3-month time-point may well develop further so that by the end of a chronic study the MTD has been exceeded by far. Even the second dose level which may not lead to significant responses by 3 months may do so at the end of a 2-year study. Moreover, no recommendations were made as to the degree of a response for the abovelisted specific end points. Another difficulty previously mentioned is whether a subchronic study (13 weeks) is sufficient to estimate the MTD for a chronic study. Figure 5 shows the results of a 2-year inhalation study in rats exposed to diesel exhaust at three different concentrations (41) . Bronchoalveolar lavages and evaluation of cellular and biochemical parameters were performed at 6, 12, and 24 mnonths of exposure. As Figure 5 shows, there is a significant shift in the shape of the exposure-response (inflammatory response determined by neutrophils in lung lavage) relationship over time. The mid-concentration of 3.5 mg/m3 showed only a slight increase in lavaged neutrophils of approximately 10% at 6 months of exposure, which is probably not indicative of an MTD being reached. However, at 12 months of exposure, lavaged neutrophils from rats of this exposure group had increased to 40%, which would likely be indicative of the MTD being reached or even exceeded; the neutrophil count in this group was even higher at 24 months of exposure. Only animals exposed to the mid and high concentrations in this particular study had increased lung tumor incidence (42) , a result associated with a state of lung particle overload. Only the lowest concentration failed to induce lung tumors in the exposed rats, but even this concentration at the 24-month time point showed significant elevation of lavaged neutrophils (-27%). A subchronic 3-month study likely would not have given an indication that an MTD had been achieved based on the results of lavage analysis. Other end points mentioned above obviously would also need to be examined; however, the difficulty of using a 3-month study for predicting the MTD for the chronic study is quite obvious from this example.
Exposure, mg/m3 Figure 5 . Exposure-response relationship in rats chronically exposed to three concentrations of diesel exhaust, with measurement of lung lavage neutrophils after 6, 12, and 24 months of exposure (41) . PMN, lung lavage neutrophils. Note the shift in the shape of the response curves with increasing duration of exposure (7) .
At present, no appropriate user friendly definition of MTD for particle inhalation studies is available. One problem relates to the fact that we do not know whether the mechanisms that lead to lung tumors in rats after inhalation of particles are also operating in humans. However, the knowledge that some particulate compounds are known to be human carcinogens and are also known to have induced lung tumors in long-term rat inhalation studies could be used to characterize the MTD, and to validate and even quantify the specific end points listed previously so that they can be used for future studies with unknown particulate compounds.
De.ninghLe MTD for Partide Inhalation Studies
Numerous chronic rat inhalation studies with fibrous and nonfibrous particles have been and are still performed with highest exposure concentrations assumed to be at the MTD. This assumption is based on an evaluation of changes in the target organ including several of the noncarcinogenic parameters suggested in the previous section, i.e., histopathology, particle dosimetry, lung weight, bronchoalveolar lavage parameters, and also the function ofAM-mediated particle clearance. Significant changes in these parameters are taken as an indication of the MTD. Although this is consistent with suggestions made by scientists from regulatory agencies, academie, and industry, it is still disputed as to whether in a given case the MTD has been achieved inspite of significant changes in the target organ. One problem is a lack of exposure-dose-response information for changes in these noncarcinogenic end points that can occur in rats after subchronic/chronic exposure to a known human particulate carcinogen.
To establish an appropriate definition of the MTD for particle inhalation studies and to calibrate specific non-cancer end points to be used for this purpose, we suggest performing a chronic multidose rat inhalation study with a known human particulate carcinogen. With respect to fibrous particles, asbestos would be a good choice, possibly using a long form of amosite as has been used in a recent chronic hamster inhalation study (43) . With respect to a non-fibrous particle, crystalline silica would be an appropriate choice as it has just recently been labeled a human carcinogen based on sufficient evidence of carcinogenicity from epidemiology of occupationally exposed workers. (5) . Both amosite and crystalline silica have been shown in long-term rat inhalation studies to induce tumors in this species (44) (45) (46) (47) . However, none of these previous long-term inhalation studies was concerned with the concept of MTD, no prechronic studies were performed, nor were specific noncancer end points other than histopathology evaluated at the end of the 2- This is only a brief outline of the study; details still need to be worked out. Table 2 summarizes potential results in such study. It is assumed that at the end of the 2-year study a dose-dependent excess lung tumor incidence is observed so that the highest dose level satisfies the requirement of the MTD being reached or slightly exceeded. Toxicologically significant changes in noncancer end points at 3 months of exposure are assumed to be dose dependent, and three possible scenarios are listed in Table 2 . Scenario 1 shows significant changes in noncancer end points only at the highest dose. epidemiologic studies were exposed at or above the human MTD. In the first case, the use of the rat as a model in cancer bioassays for inhaled particles needs to be reevaluated-the rat may have to be characterized as inappropriate for this purpose. In the second case, the MTD principle may need to be extended to indude dose levels above the MTD in a rat-cancer bioassay with particles (scenarios 2 and 3 in Table 2 ). For example, the degree of an acceptable inflammatory or other toxic response may have to be greater than minimal as suggested by the present MTD concept.
Concluding Remarks
Assuming that the MTD concept has been validated by the studies outlined in the previous section and using the calibrated noncancer end points previously suggested, the carcinogenic potential of new particulate materials can be evaluated in a chronic cancer inhalation bioassay in the rat. However, regulators need to determine how to classify a particulate compound if a tumor response occurs only at and above MTD levels. Should such a compound be characterized as a possible human carcinogen? The U.S. EPA, when removing TiO2 from its toxic substances inventory (8) , used the weight of evidence approach to determine that lung tumors induced in rats at high levels of TiO2 were secondary to toxicity, based on lung particle overload. Thus, it becomes important in such cases to evaluate mechanisms of lung toxicity and carcinogenicity for fibrous and nonfibrous particles, specifically comparing low versus high doses.
For an evaluation of secondary mechanisms such as inflammation-induced carcinogenesis (Figure 3) , quantification of the specific end points of toxicity would also be very helpful. For example, the magnitude of an increase in inflammatory neutrophils in bronchoalveolar lavage and its significance for inducing mutational events in target cells may depend highly on the level of anti-inflammatory and antioxidant defenses. It may be possible to define an acceptable increase in lung lavage neutrophils (e.g., 20 or 30% of the lavaged cell population), which, although significant, may not be viewed as being above the MTD; i.e., levels of significance for toxic responses could be redefined.
It should be considered that for an evaluation of these noncancer end points only a small number of animals (-5) is necessary, whereas a carcinogenic effects study requires much greater numbers (50-100 per group) in order to detect significant tumorigenicity even at high doses. The definition of a high dose is by convention based on the gravimetric dose but should be redefined and based on the observed changes in non-cancer end points. For example, in the case of particles that have a strong inflammatory and fibrogenic potency, e.g., crystalline SiO2, the markers of inflammation will be present at much lower mass doses than with TiO2. However, at equal degrees of a chronic inflammatory response (above MTD), the lung tumor response in rats may well be the same for low dose SiO2 and high dose TiO2. What we do not know and what needs to be determined is whether the confirmed human carcinogen crystalline SiO2 also induces lung tumors in rats at or below dose levels defined as the MTD in a validation study that is designed as suggested in this paper. If tumors are not induced at lower levels, the concept of the MTD for particle inhalation studies has to be reconsidered.
Being able to define the MTD based on the outcome of a validated study is obviously important for the long-term cancer bioassay. However, such long-term inhalation studies with particles are very timeand cost-consuming, and one future goal would be to develop short-term assays that will allow us to determine the carcinogenic potential of an unknown particulate compound. With respect to fibers, one approach presently being discussed involves combining in a short-term assay the evaluation of the biodurability of an unknown fiber with evaluation of specific end points of toxicity after an inhalation exposure as short as 5 days with subsequent sufficient time for observation. This short-term assay for fibers is based on the rationale that a fiber that is dissolved within a short period of time in the lung will no longer be fibrogenic or carcinogenic. The concept of biodurability for long-term chronic effects is also principally applicable to nonfibrous particles, e.g., crystalline silica (poorly soluble) versus amorphous silica (soluble in the lung). However, for the development of short-term assays, more research is still needed to gain insight into the mechanisms of particle-induced lung tumors so that future assays, either in vivo or in vitro, can be based on a better knowledge of cellular/molecular events.
Another important research area to be addressed in future studies is the significant species difference in response between rats on the one hand and mice and hamsters on the other . Why are mice and hamsters less susceptible to pulmonary inflammation, fibrosis, and carcinogenicity? With respect to the inflammatory mechanisms of lung tumor induction, a number of questions could be answered by evaluating species differences in the recruitment of neutrophils to the lung and their state of activation; investigating the mutagenic potential of activated neutrophils from mice and hamsters to epithelial target cells; or determining the response of lung epithelial cells from mice and hamsters to mutagenic stimuli in comparison to rat epithelial cells. To answer these and other related questions would give important insight into reasons for the apparent resistance of some rodent species to lung tumor induction by particles. Finally, a significant gap in our knowledge needs to be closed by comparing rodent and human responses using lung cells from these species for evaluation of cellular and molecular events. The hope is that mechanistic knowledge gained from these studies will in the future permit us to replace the long-term cancer bioassay with acceptable short-term assays.
